Experiments such as using CRISPR-Cas9 system to knockout FGFR1 gene in DU145 to generate a new experiment system—FGFR1 null DU145 cells are needed to confirm the link between FGFR1 and LDHA with tumor cell phenotype. This evidence concerns the gene LDHA and neoplasm.